Выпуск
Pharmaceutical Executive Daily: FDA Grants Accelerated Approval to Jemperli
Pharmaceutical Executive · 20 октября 2026 г. · 2 мин
METiS TechBio and Eli Lilly collaborate on next-generation LNP delivery technology, Incubate’s John Stanford on how MFN deals may shape future pharma decisions, and the FDA grants accelerated approval to GSK’s Jemperli for MSI-H/dMMR locally advanced rectal cancer.